Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of NIH 3T3 and HepG2 cells after arsenite treatment

ABSTRACT: RNA-seq of NIH 3T3 and HepG2 cells after arsenite treatment

PROVIDER: PRJNA483222 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR7613060.fastq.gz	Fastqsanger.gz
	SRR7613061.fastq.gz	Fastqsanger.gz
	SRR7613062.fastq.gz	Fastqsanger.gz
	SRR7613063.fastq.gz	Fastqsanger.gz
	SRR7613064.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

RNA-seq of NIH 3T3 and HepG2 cells after arsenite treatment

Project description:Expression profiling of HepG2 human liver carcinoma cells and NIH 3T3 mouse fibroblasts after arsite treatment for 24h. RNA-seq data comprise 4 groups: NIH 3T3 mouse fibroblasts control and arsite treatment, and HepG2 human liver carcinoma cells control and arsenite treatment. Jena Centre for Systems Biology of Ageing - JenAge (www.jenage.de)

2021-10-19 | GSE117815 | GEO

NIH 3T3: Ctrl vs Reo

Project description:Transcriptional profiling of NIH 3T3 comparing WT, RIG-I KD with and without reovirus infection

2020-10-07 | GSE127850 | GEO

NIH 3T3: Ctrl vs Reo

Project description:NIH 3T3: Ctrl vs Reo

| PRJNA525645 | ENA

Immediate Early Response 2 (Ier2) overexpression effect in NIH 3T3 cells

Project description:Analysis of Immediate Early Response 2 (Ier2)-inducible NIH 3T3 cells after Ier2 induction with RheoSwitch ligand RSL-1. Results provide insight into the function of Ier2 in NIH 3T3 mouse embryonal fibroblasts. Immediate early genes, including Ier2, are rapidly induced in quiescent cells by proliferation and migration-inducing stimuli. Microarray gene expression profiling was performed to identify differentially expressed genes following overexpression of Ier2 in NIH 3T3-Ier2 inducible cells after 24 hour induction of Ier2.

2021-10-07 | GSE181200 | GEO

dynamic SILAC NIH/3T3 treated with DMSO/CHX

Project description:NIH/3T3 cells were cultured at least 2 weeks in light medium: DMEM for SILAC (Thermo scientific) supplemented with PS, dialyzed FBS (Thermo scientific), (light) L-Lysine-2HCl (0.666 mM), (light) L-Arginine-HCl (0.399 mM)44, and L-Proline (200 mg/L). Before switching from light to heavy medium, cells were treated with 0.05 µg/mL CHX or equivalent dilution of DMSO in 6-well plates. At timepoint 0 h, we replaced light medium with pre-warmed heavy medium: DMEM for SILAC (Thermo scientific) supplemented with PS, dialyzed FBS (Thermo scientific), (heavy) 13C6 15N2 L-Lysine-2HCl (0.666 mM), (heavy) 13C6 15N4 L-Arginine-HCl (0.399 mM), and L-Proline (200 mg/L) for NIH/3T3.

2025-10-07 | PXD061384 | Pride

NIH-3T3 cell line response to chemotheraputic agents.

Project description:In this study, we treated NIH-3T3 cells with various chemotherapy drugs and RNA sequencing analysis was carried out.

2025-12-03 | GSE262174 | GEO

RNA-Seq of NIH-3T3 cells treated with CMA modulators

Project description:Transcriptomics of NIH-3T3 cells treated with CMA activators to evaluate gene expression changes

2022-06-06 | GSE194292 | GEO

Genome wide mapping of LSD1 binding sites in NIH/3T3

Project description:We provide the binding sites of LSD1 in NIH/3T3 cells mapped via ChIP-seq

2021-03-09 | GSE158441 | GEO

Alterations of miRNAs in NIH/3T3 cells overexpressing BPV-13 E6

Project description:To find out differentially expressed miRNAs in NIH/3T3 cells overexpressing BPV-13 E6